Department of Radiology and Radiological Sciences Grand Rounds
Tenth Annual Sandler Lecture in Nuclear Medicine and Molecular Imaging
"Living with a Rare Cancer - My Dr. Seuss World"
Josh Alan Mailman, B.A.
President, NorCal CarciNET Community
COO, World Association of Radiopharmaceutical and Molecular Therapy
Oakland, California
Monday, May 22, 2017
Noon - 1 p.m.
MCN CCC-1111
---------------------------------------------------------------
This grand round is designed for faculty, residents, staff and medical students.
Learning objectives of this presentation:
1) Contrast the standard of care for NET patients around the world
2) Evaluate “Theranostics” and its implication for NET patients in the U.S. and around the world
3) Assess models of medical societies and patient advocates working together to better patient care
4) Analyze the role that patient advocacy plays in patient education
Sponsored by Vanderbilt University School of Medicine, Department of Radiology and Radiological Sciences.
Vanderbilt University Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Vanderbilt University Medical Center designates this live activity for a maximum 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Jeff L. Creasy, M.D., CME Activity Director, has no financial relationships related to the content of this activity to disclose. Josh Alan Mailman, B.A., presenter, has no financial relationships related to the content of this activity to disclose. This educational activity received no commercial support.
This educational activity received no commercial support.
+++
Josh Alan Mailman holds a Bachelor of Arts in Economics and an MBA in Marketing and Finance from the University of California at Los Angeles Anderson School of Management. He is a Silicon Valley executive with more than 20 years of success in the technology field. Mailman cocreated eFax.com where he served as Vice President of Operations and received several patents for his work on eFax’s technology. During his career, Mailman has held executive level positions at Xerox, NBCi and Everyone.net. His last startup, ChatterEmail, was sold to Palm in 2007.
Since his diagnosis in 2006, Mailman has focused his time and energy in the nonprofit community. He is president of the Northern California CarciNET Community (NorCalCarciNET.org) and the COO of the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH.org). Mailman is also a member of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging where he was the inaugural chair. He is also a member of the NCI task force for Neuroendocrine Tumors. He is on the board of the Neuroendocrine Tumor Research Foundation (NETRF), the Education and Research Foundation for Nuclear Medicine and the North American Neuroendocrine Tumor Society’s Advisory Board.